chrisvoncsefalvay/vaers-outcomes huggingface dataset:
forearm went completely numb as well as the right side of my face; blood pressure also went up; This case was reported by a consumer and described the occurrence of numbness of upper extremities in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number HM21H, expiry date unknown) for prophylaxis.   Concurrent medical conditions included osteoporosis and food allergy (allergic to sesame seed).   On 8th October 2021, the patient received Shingrix .5 ml. On 8th October 2021, immediately after receiving Shingrix, the patient experienced numbness of upper extremities and increased blood pressure. On an unknown date, the outcome of the numbness of upper extremities and increased blood pressure were recovered/resolved.   It was unknown if the reporter considered the numbness of upper extremities and increased blood pressure to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The patient received Shingrix vaccine and within 3 minutes of receiving the shot, her forearm went completely numb as well as the right side of her face including my ear (on same side where the shot was administered) and her blood pressure also went up. The reporter stated that the nurse called it an unusual and immediate reaction to Shingrix. The patient reported that everything went back to normal within 30 minutes.
Had Blood clots shortly after that ended up with a pulmonary embolism and had vision lost and have eye issues.   Went to the hospital on 8/13/2021. eye issues continue and not on blood thinners
On 02/28, mother recalled to report a 2-3" area of swelling and erythema -  'tennis ball size.' Itchy, grumpy over the past 2 days. Improving now with Ibuprofen and Benadryl on left thigh. Right thigh had no reaction.
I waited 20 minutes before leaving the pharmacy.  Within 5 minutes the severe abdominal cramps started and continue the remainder of Sunday.  The intensity of the cramps decreased Monday and Tuesday.  Tuesday evening I noticed a small amount of brownish discharge that I would normally see after my period.  The discharge continued until Wednesday.    All symptoms had dissipated by Thursday of the same week.
This case was reported by a physician via sales rep and described the occurrence of stiff neck in a adolescent patient who received BEXSERO. Co-suspect products included BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO .5 ml and the 2nd dose of BEXSERO .5 ml. On an unknown date several weeks after receiving BEXSERO and BEXSERO, the patient experienced stiff neck, fever, drowsiness and adverse event. On an unknown date, the outcome of the stiff neck and drowsiness were recovered/resolved and the outcome of the fever was not recovered/not resolved and the outcome of the adverse event was unknown. It was unknown if the reporter considered the stiff neck, fever, drowsiness and adverse event to be related to BEXSERO and BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional reported that the patient experienced side effects after 1st dose or 2nd dose of BEXSERO. The healthcare professional was concerned that the side effects resembled symptoms of the disease so the patient was referred to the hospital to have lab work and the lab work came back and everything was negative. The healthcare professional also reported that several side effects occurred approximately 16 days after the vaccine was administered.
MOTHER REPORTS ON 09 DEC 17, PATIENT STARTED WITH REDDENED RAISED REGION AT PEDIARIX VACCINATION SITE. RASH THEN SPREAD OVER A 24 HOUR PERIOD FROM VACCINATION SITE ACROSS ENTIRE BODY. NO OTHER SYMPTOMS ASSOCIATED WITH RASH. RASH RESOLVED ON OWN OVER 36 TO 48 HOUR PERIOD WITH NO COMPLICATIONS. MOTHER HAS PICTURES OF RASH AND SHOWED THEM TO RN. RASH NONTOXIC MACULOPAPULAR IN APPERANCE.
Systemic: shortness of breath-Severe, Systemic: Hypertension-Severe, Systemic: Hyperventilation-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Severe
Patient called 3 days after receiving vaccine, stating blurred vision in only his left eye. Advised patient should reach out to his PCP as soon as possible or go to urgent care if his symptoms worsen.
Developed fever 99-102, convulsion, resp arrest, nausea & vomiting. Seen in ER and revived. Hospitalized x 2 days w/dx viral related. Also had febrile seizures, limp, lethargic, retractions w/ respirations.  Positive for ear infection.
After receiving her vaccine, client stated she has a tingling sensation of her tongue.  Vital signs obtained by EMS.  BP 145/90, HR 80, O2 sat 99%. Client states she feels better.  Client discharged home by EMS.
12/15/2020 I was tired, body chills, pain in left arm but was all very light until 12/16/2020 headache was more severe
Within 30 minutes of vaccination, there was tongue numbness and tingling in addition to chest tightness. After 5 hours there was also upper lip numbness and tingling. Benadryl 50mg po was given in Emergency department of Hospital (where patient is a resident physician) and patient took another 25mg po Benadryl before bedtime. Tongue numbness improved by next morning, however upper lip numbness persisted. There was also upper lip swelling the next morning after vaccine, which was noticed when patient woke up (~ 16 hours after vaccination). This was treated with 20 mg cetirizine in AM and 10mg cetirizine at night by patient. Swelling persisted into the following day ~ 48 hours post vaccination before resolving. Patient?s initial chest tightness resolved within the few hours of observation in ED.
Patient was administered the 1st ROTATEQ dose at 13 to 14 months of age; no adverse event; This spontaneous report was received from a other health professional refers to a patient of 13 to 14 months of age of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On an unknown date, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) orally (dose, frequency, lot# and expiration date were not provided), for prophylaxis.
Pfizer Booster given to 13 y/o patient. No adverse reaction was reported. Pts mother was present during the time of the vaccine and also notified after that the booster is not approved for 13 y/o
Within 30 minutes I began having tinnitus - duration approximately 36 hours. Within 2 hours I began feeling unbalanced/dizzy.  Not vertigo, as it was only while moving. From 13 days after the injection (8/20/21) through 8/30/21 I experienced periodic neuropathic pains in my toes and face.
Injection site reaction - complained of redness/itching/soreness inflammation on 5/23/16 marked the margins. On 5/24/16 patient returned and redness had increased to 3 in wide by 4 in long was hard, swollen, red, hot. Contacted PCP he prescribed prednisone 20 mg 2 tabs x 4 days to decrease inflammation.
Initial information received on 08-Mar-2019 regarding an unsolicited valid non-serious case received from a other health care professional. This case involves a 16 years old patient (gender unknown) who received MENACTRA instead of the 2nd dose of TRUMENBA. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Jul-2018, the patient received a first dose of suspect TRUMENBA not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site. On 05-Feb-2019, the patient received a dose of suspect MENACTRA lot number not reported via unknown route in unknown administration site. It was an actual medication error due to wrong vaccine administered. A patient received MENACTRA instead of the 2nd dose of TRUMENBA. It was unknown whether patient experienced any adverse event following vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Bad reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Smoker.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Bad reaction). At the time of the report, VACCINATION COMPLICATION (Bad reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) Blood pressure spike.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This patient was in her 60s. No relevant concomitant medications were provided. No treatment information was provided.
42yr old patient with PMH of kidney transplant (1994, 1999), chronic insomnia, thrombocytopenia, and other comorbidities presented to clinic for follow up of abdominal pain on 11/23.  During visit, patient requested to receive vaccines as recommended by GI.  MD entered orders for Hepatitis A vaccine adult IM, Heplisav-B, Hepatitis B Vaccine (Recombinant), Adjuvant, and Pneumococcal polysaccharide vaccine 23-valent greater than or equal to 2yo SQ/IM (PNEUMOVAX-23).  CMA prepared vaccines and administered the following:  Hepatitis A vaccine (LOT # X9A9B, GSK) IM to patient?s LD, Hepatitis B vaccine (LOT # 934599, Dynavax) IM to patient?s LD, and Pneumococcal P23V vaccine (LOT # T021485, Merck) IM to patient?s LD.  Later patient endorsed headache and left arm pain within 2hrs of vaccination and gradual immobility of left should due to swelling and pain.  Patient endorsed icing, applying heat, and acetaminophen with no improvement.  Patient reevaluated in office on 11/24 with no indication of anaphylaxis, but positive for erythematous rash along left deltoid area with swelling and tenderness as well as poor range of motion of left shoulder.  Of note, follow up not on 11/24 states hepatitis A and B vaccines administered to RD, not LD as documented in Immunizations.  Patient given should slinger for support and advised to monitor.  Patient discharged home in stable condition.   Of note patient administered HPV vaccine on 11/18/20 in LD.
I was vaccinated on 12-30 after 4 pm.  By 3:30 on 12-31 my neck quickly swelled up, my throat becoming sore, glands swollen, headache, and fatigue were my first symptoms. An unusual symptom occurred from day 2-6. My facial skin did not hurt unless I applied pressure. When I applied pressure it felt bruised and highly sensitive but didn't hurt unless pressure was applied.  I also developed a small sore along my gum line on the bottom right front of my mouth.  Both of these symptoms disappeared after day 6. 7-8 days after receiving the vaccine my neck, jaw and shoulders became extremely stiff, including a runny nose. This symptom has persisted and is the worst of all symptoms (jaw and neck stiffness and sore throat). On day 12 in addition to the ongoing sore throat,  and stiffness in my neck and jaw I developed white spots on my right tonsil.  3 days after the white spots disappeared, but the red sore throat is current. On day 20, I developed 2 more sores on the right side of my mouth. One on the bottom gum line and one on the top right gum line (this feels like a canker sore). Today I have a slight earache in my right ear.   NOTE: I tested positive to COVID June 2020. I ended up taking 1 month off work due to persistent symptoms. I still cannot properly smell and taste, and I can smell water.  Occasionally, the brain fog from COVID comes up but that is more rare.
Starting on Tues eve (2/3) pat experienced itching woke up w/blistering rash on waist, under breast & arm pits - itchy & red
Admitted to Hospital on 2/25/21 with 1 day of severe upper extremity weakness and numbness. Evaluated by Neurology and Neurosurgery teams and thought to be most consistent with transverse myelitis. Infectious Diseases consult and no clear preceding infectious illness.
This spontaneous report as received from a pharmacist, refers to a female patient, who is currently 66 years old. Although no concurrent conditions were reported, she did have a history of adverse reactions with an unspecified penicillin and SULFA. On 29-MAR-2016, the patient was vaccinated with 0.65 ml dose of ZOSTAVAX, subcutaneously (which had a lot # of L031271 and expiration date of 19-NOV-2016; however, dosage number and anatomical location were not reported). No concomitant medications were reported. Subsequently, on an unspecified date in 2016, the patient experienced an injection site reaction described as something that looked like a bruise at the site of injection. Reportedly, it did not hurt unless a push was applied on the site (injection site bruising)(injection site pain). The patient sought medical attention by contacting the pharmacist. Furthermore, it was reported that the events had lasted for over 30 days and at the time of reporting, the patient had recovered from them. The reporter failed to provide any causal relationship between the events and the vaccination with ZOSTAVAX. Additional information has been requested.
dog bite; HCP recommended to update her tetanus shot / second dose of the covid vaccine is scheduled on 20Jan2021; HCP recommended to update her tetanus shot / second dose of the covid vaccine is scheduled on 20Jan2021; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received the first dose of BNT162B2 (lot no. and expiry date were not reported), via an unspecified route of administration on 30Dec2020 at single dose for Covid-19 Vaccine and tetanus vaccine (manufacturer unknown) via an unspecified route of administration on unspecified date at single dose for dog bite. The patient's medical history and concomitant medications were not reported.  Last night on unspecified date, the patient got a dog bite and her HCP recommended to update her tetanus shot, however her second dose of the covid vaccine is scheduled on 20Jan2021. She wanted to know if there are any recommendations for this. The outcome of the event was unknown.  Information on Lot/Batch number has been requested.; Sender's Comments: The event dog bite is due to an external factor and is considered unrelated to BNT162B2.
Date of Admission: 10/17/2022 Date of Discharge: 10/21/2022 Attending Provider: DO Primary Care Provider: MD      Diagnoses on Admission Order: Altered mental status, unspecified altered mental status type [R41.82]    Hospital Principal Problem (Discharge Diagnoses): COVID-19
1st Shot 04/15/2021, 2nd Shot 05/06/2021. On the weekend of April 24, I found a marble size lump above my neck line on the left hand side. It was painful, moved around, and felt swollen. The following Monday April 26, I went into Urgent Care. Dr. stated that I had a small sausage sized, swollen lymph node. I flinched from pain several times. He sent me for bloodwork, chest x-ray, and ultrasound, which I did blood and x-rays on that same day. I had made appointment for ultrasound on May 13. Dr. also called me on that day to say that there were no signs of cancer and to follow up with my dr. I have appointment with her June 29.
Chills; Aching; Nausea; Diarrhea; Weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the right arm on 02Mar2021 at 09:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19. The patient did not have any known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021, the patient experienced chills, aching, nausea, diarrhea and weakness. Since the vaccination, the patient had not been tested for COVID-19. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome for the events chills, aching, nausea, diarrhea and weakness were resolved on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
PATIENT REPORTS SITTING AT KITCHEN TABLE WITH HER KIDS AND TALKING ON THE PHONE WITH HER MOM, SHE HAD SUDDEN ONSET OF NOT BEING ABLE TO TALK FOLLOWED BY LOSS OF CONCIOUSNESS, ALSO REPORTS INJECTION SITE PAIN AND REDNESS. SHE WAS TRANSPORTED TO THE HOSPITAL WHERE THEY DREW BLOOD AND RAN A CT SCAN, PATIENT WAS NOT AWARE OF THE TESTS RAN, THEY WERE REPORTED TO HER BY HER HUSBAND AFTER SHE WAS RELEASED. PATIENT WAS RELEASED LATER THE SAME DAY WITHOUT DIAGNOSIS OR MEDICATIONS.
This spontaneous report as received from a other health professional refers to a patient of unknown age and gender. On 13-MAR-2014 the patient was vaccinated with PEDVAX (lot number, dose and frequency not provided), intramuscular. The patient received the vaccine which was exposed to 39 degrees F for 1 hour. No known adverse effects. Additional information has been requested.
Febrile seizure after set of above shots.  T 101.  Neuro exam normal.  Unclear what specific vaccine.
pt recvd vax & exp lightheadedness, dizziness, & clamminess;
No adverse reaction reported by patient. Patient received extra dose of DTAP and MMRV.
Severe chest pain after vaccination, found to have diffuse ST segment changes and elevated troponin consistent with myopericarditis.
Debilitating fatigue,  fever,  sore throat, chills, cervical lymphadenopathy, all lasting 36 hours.
My son took the first dose of Moderna in April.  He was out of the country for 2 months and is just now getting his second dose.; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My son took the first dose of Moderna in April.  He was out of the country for 2 months and is just now getting his second dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My son took the first dose of Moderna in April.  He was out of the country for 2 months and is just now getting his second dose.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My son took the first dose of Moderna in April.  He was out of the country for 2 months and is just now getting his second dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Swelling in lymph node at collarbone on side of injection.  Is painfully lump that moves.
This is a spontaneous report from a contactable pharmacist. A 78-year-old female patient of unspecified ethnicity received PREVNAR 13, intramuscular, on 17Feb2015, at 0.5 ml single. Relevant medical history included psoriasis treated with methotrexate (unspecified trade name). The patient had no drug allergies and was not an alcohol abuser. Family history was not reported. Concomitant medication included methotrexate (unspecified trade name), via an unspecified route of administration, from 17Feb2015, at 10 mg weekly (4 tablets weekly), for psoriasis. On unspecified date in Feb2015 the patient experienced insomnia, increased thirst, muscle pain, weakness and feeling unwell. The events caused patient's hospitalization for 1 day. Therapeutic measures were taken as a result of the events and included BENADRYL. The patient recovered from the events on 21Feb2015. Follow-up (18Feb2015): New information from the same contactable pharmacist includes: vaccination partial date, events partial onset date, vaccine posology, additional event feeling unwell, patient inquiry. Follow-up (17Mar2015): new information received from the same contactable pharmacist includes: PREVNAR 13 details, events details, concomitant medication, medical history. Follow-up attempts completed. No further information expected.
A week following covid vaccine my left arm started to have a severe burning sensation, turned bright red at about a 3 inch diameter, was hot to the touch, and the skin itself itches and burned at the same time. I contacted Doctors CAre and they prescribed me to use warm compresses and started me on Bactrim DS twice daily x 7 days. I also took ibuprofen for the swelling and pain.
The day after receiving the vaccine, PT became confused and collapsed at home. He could not move and was extremely weak. His wife called 911 and he was taken to the hospital where he stayed over night. At hospital, they were told his condition was due to receiving the vaccines.
Patient received booster dose of Moderna covid bivalent before primary series was given. Patient still needs to have dose 1 and dose 2 of primary series. No symptoms of interaction.
Swelling of Hands and Numbness especially in the AM and PM noticed the following morning 2/27 at 8:00 am.   Petechiae all over torso from underneath breasts, to the upper thighs noticed on 2/27 at 10:00 pm. Took Benadryl 25 mg. at 11:30 pm. Petechiae seems to have reduced by 10% but swelling remained same. Contacted Physician via after hours. On call Physician recommended dose of Benadryl or other Non-Drowsy allergy medication. Took Fexofenadine 180mg at 11:00 am on 2/28/21.
By 8pm started feeling achy, and with flu-like symptoms which lasted for about 3 days. On the first night, had body aches and took Advil which helped relief symptoms a little.  Patient also felt tired and had little energy; patient still went to work but did not feel well.  On Thursday morning, patient felt tingling on back so took 1 Famvir; only took 1 as read that it was a contraindication on paperwork.  Patient also spoke to a pharmacist about taking Famvir.   Patient reports vaccination site was red, warm, and had an itchy feeling near elbow; no bumps seen. Patient still feels tingling 6 days later.
Patient experienced tachycardia, chills, and itch within 15 minutes of observation.   No treatment was given.  Patient was observed and later discharged
Patient experienced severe inflammation, swelling, pain, and weeping edema from elbow to shoulder in arm that received injection. Patient advised to go to ER if worse, however, it is unknown if patient needed to go to ER.